Version 5.4
Bos taurus Gene: NOL9
Summary
InnateDB Gene IDBG-633805.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol NOL9
Gene Name Polynucleotide 5'-hydroxyl-kinase NOL9
Synonyms
Species Bos taurus
Ensembl Gene ENSBTAG00000016733
Encoded Proteins
IDBP-685552
Polynucleotide 5'-hydroxyl-kinase NOL9
Protein Structure
Useful resources Stemformatics EHFPI ImmGen
Entrez Gene
Summary This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000162408:
Gene Information
Type Protein coding
Genomic Location Chromosome 16:47678491-47693841
Strand Forward strand
Band
Transcripts
ENSBTAT00000022240 ENSBTAP00000022240
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 5 interaction(s) predicted by orthology.
Predicted by orthology
Total 5 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0000166 nucleotide binding
GO:0003723 RNA binding
GO:0005524 ATP binding
GO:0016301 kinase activity
GO:0016740 transferase activity
GO:0051731 polynucleotide 5'-hydroxyl-kinase activity
Biological Process
GO:0000460 maturation of 5.8S rRNA
GO:0006364 rRNA processing
GO:0016310 phosphorylation
Cellular Component
GO:0005634 nucleus
GO:0005730 nucleolus
GO:0016020 membrane
Orthologs
Species
Homo sapiens
Mus musculus
Gene ID
Gene Order
ENSG00000162408
View Gene Order
ENSMUSG00000028948
View Gene Order
Cross-References
SwissProt
TrEMBL
UniProt Splice Variant
Entrez Gene
UniGene Bt.103226
RefSeq NM_001206599
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL
GenPept
RNA Seq Atlas

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca